News and Updates
Potential Risk of Exposure to Toxic Compounds – Hemodialysis and Peritoneal Dialysis Systems
The U.S. Food and Drug Administration (FDA) is continuing to evaluate the potential risk of exposure to toxic compounds when using dialysis systems. On May 6, 2022, the FDA issued
Update: Reduce the Risk for Medical Device Misconnections
Today, the U.S. Food and Drug Administration (FDA) added a new case study to its “Examples of Medical Device Misconnections” webpage. The webpage describes device misconnections based on reports of
Class 1 Recall Smiths Medical Recalls Certain CADD System Administration Sets and Cassette Reservoirs
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Device Use CADD ambulatory
Outbreak of Extensively Drug-resistant Pseudomonas Aeruginosa Associated with Artificial Tears
The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory about infections with an extensively drug-resistant strain of Verona Integron-mediated Metallo-β-lactamase (VIM) and
Medtronic Recalls Mahurkar Acute Dual Lumen High Flow Hemodialysis Catheters for Potential Catheter Hub Defect
Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters are implanted and used in hemodialysis (treatment to filter waste and water from the blood), apheresis (a technology that separates
Prolia (denosumab) by Amgen: Investigating Risk of Severe Hypocalcemia in Patients on Dialysis
The U.S. Food and Drug Administration (FDA) is investigating the risk of severe hypocalcemia with serious outcomes, including hospitalization and death, in patients with advanced kidney disease on dialysis treated
Subscribe to our Newsletter
Newsletter Archive
Vaccination
- 2023 Vaccine Campaign
- Vaccination Month Series